169 related articles for article (PubMed ID: 22882857)
1. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
Chen YH; Wu ZQ; Zhao YL; Si YL; Guo MZ; Han WD
Chin Med J (Engl); 2012 Jul; 125(13):2329-33. PubMed ID: 22882857
[TBL] [Abstract][Full Text] [Related]
2. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
3. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
[TBL] [Abstract][Full Text] [Related]
4. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
5. Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer.
Shuno Y; Tsuno NH; Okaji Y; Tsuchiya T; Sakurai D; Nishikawa T; Yoshikawa N; Sasaki K; Hongo K; Tsurita G; Sunami E; Kitayama J; Tokunaga K; Takahashi K; Nagawa H
J Surg Res; 2010 Jun; 161(1):76-82. PubMed ID: 19515385
[TBL] [Abstract][Full Text] [Related]
6. Synergistic repression of estrogen receptor transcriptional activity by FHL2 and Smad4 in breast cancer cells.
Xiong Z; Ding L; Sun J; Cao J; Lin J; Lu Z; Liu Y; Huang C; Ye Q
IUBMB Life; 2010 Sep; 62(9):669-76. PubMed ID: 20734429
[TBL] [Abstract][Full Text] [Related]
7. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
[TBL] [Abstract][Full Text] [Related]
8. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
9. The LIM-only protein FHL2 regulates interleukin-6 expression through p38 MAPK mediated NF-κB pathway in muscle cells.
Wong CH; Mak GW; Li MS; Tsui SK
Cytokine; 2012 Aug; 59(2):286-93. PubMed ID: 22633286
[TBL] [Abstract][Full Text] [Related]
10. FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells.
Ng CF; Ng PK; Lui VW; Li J; Chan JY; Fung KP; Ng YK; Lai PB; Tsui SK
Cancer Lett; 2011 May; 304(2):97-106. PubMed ID: 21377781
[TBL] [Abstract][Full Text] [Related]
11. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
Li M; Wang J; Ng SS; Chan CY; Chen AC; Xia HP; Yew DT; Wong BC; Chen Z; Kung HF; Lin MC
Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
[TBL] [Abstract][Full Text] [Related]
12. XIAP-associated factor 1 interacts with and attenuates the trans-activity of four and a Half LIM protein 2.
Zhang W; Yang Y; Jiang B; Peng J; Tu S; Sardet C; Zhang Y; Pang R; Hung IF; Tan VP; Lam CS; Wang J; Wong BC
Mol Carcinog; 2011 Mar; 50(3):199-207. PubMed ID: 21104993
[TBL] [Abstract][Full Text] [Related]
13. FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells.
Martin BT; Kleiber K; Wixler V; Raab M; Zimmer B; Kaufmann M; Strebhardt K
Cell Cycle; 2007 Jul; 6(14):1779-88. PubMed ID: 17682292
[TBL] [Abstract][Full Text] [Related]
14. Modulation of aryl hydrocarbon receptor activity by four and a half LIM domain 2.
Kollara A; Brown TJ
Int J Biochem Cell Biol; 2009 May; 41(5):1182-8. PubMed ID: 19015043
[TBL] [Abstract][Full Text] [Related]
15. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
Kleiber K; Strebhardt K; Martin BT
Anticancer Res; 2007; 27(1A):55-61. PubMed ID: 17352216
[TBL] [Abstract][Full Text] [Related]
16. Identification of FHL2-regulated genes in liver by microarray and bioinformatics analysis.
Ng CF; Xu JY; Li MS; Tsui SK
J Cell Biochem; 2014 Apr; 115(4):744-53. PubMed ID: 24453047
[TBL] [Abstract][Full Text] [Related]
17. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
[TBL] [Abstract][Full Text] [Related]
18. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
20. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
Singh J; Murata K; Itahana Y; Desprez PY
Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
